Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

401 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Endoscopic submucosal dissection for early gastric cancer on the lesser curvature in upper third of the stomach is a risk factor for postoperative delayed gastric emptying.
Yoshizaki T, Obata D, Aoki Y, Okamoto N, Hashimura H, Kano C, Matsushita M, Kanamori A, Matsumoto K, Tsujimae M, Momose K, Eguchi T, Okuyama S, Yamashita H, Fujita M, Okada A. Yoshizaki T, et al. Among authors: momose k. Surg Endosc. 2018 Aug;32(8):3622-3629. doi: 10.1007/s00464-018-6091-6. Epub 2018 Feb 7. Surg Endosc. 2018. PMID: 29417229
A Comparative Study of a New Class of Gastric Acid Suppressant Agent Named Vonoparazan versus Esomeprazole for the Eradication of Helicobacter pylori.
Tsujimae M, Yamashita H, Hashimura H, Kano C, Shimoyama K, Kanamori A, Matsumoto K, Koizumi A, Momose K, Eguchi T, Fukuchi T, Fujita M, Okada A. Tsujimae M, et al. Among authors: momose k. Digestion. 2016;94(4):240-246. doi: 10.1159/000454762. Epub 2016 Dec 29. Digestion. 2016. PMID: 28030862 Free PMC article.
The Effects of Switching to Vonoprazan, a Novel Potassium-Competitive Acid Blocker, on Gastric Acidity and Reflux Patterns in Patients with Erosive Esophagitis Refractory to Proton Pump Inhibitors.
Yamashita H, Kanamori A, Kano C, Hashimura H, Matsumoto K, Tsujimae M, Yoshizaki T, Momose K, Obata D, Eguchi T, Fujita M, Okada A. Yamashita H, et al. Among authors: momose k. Digestion. 2017;96(1):52-59. doi: 10.1159/000478255. Epub 2017 Jun 30. Digestion. 2017. PMID: 28662503
Real-World Comparison of Elobixibat and Lubiprostone Treatment in Patients with Chronic Constipation: A Propensity Score-Matched Analysis.
Eguchi T, Yoshizaki T, Ikeoka S, Takagi M, Fujinami M, Matsuda T, Yamaguchi T, Nonaka T, Amioka S, Katayama N, Inoue K, Matsumoto M, Momose K, Sako T, Noda M, Morisawa T, Okada A. Eguchi T, et al. Among authors: momose k. Dig Dis. 2021;39(4):341-350. doi: 10.1159/000512745. Epub 2020 Nov 3. Dig Dis. 2021. PMID: 33142288
Propensity score matching analysis: incidence and risk factors for "stardust" gastric mucosa, a novel gastric finding potentially induced by vonoprazan.
Yoshizaki T, Morisawa T, Fujinami M, Matsuda T, Katayama N, Inoue K, Matsumoto M, Ikeoka S, Takagi M, Sako T, Momose K, Noda M, Eguchi T, Okada A. Yoshizaki T, et al. Among authors: momose k. Aliment Pharmacol Ther. 2021 Jan;53(1):94-102. doi: 10.1111/apt.16151. Epub 2020 Nov 7. Aliment Pharmacol Ther. 2021. PMID: 33159407
401 results